Edap Tms (NASDAQ:EDAP) Stock Rating Upgraded by StockNews.com

Edap Tms (NASDAQ:EDAP) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Wednesday.

Separately, HC Wainwright restated a “buy” rating and set a $19.00 price objective on shares of Edap Tms in a research report on Thursday, August 29th.

Edap Tms Stock Down 1.7 %

EDAP stock opened at $2.87 on Wednesday. The company has a current ratio of 2.45, a quick ratio of 1.80 and a debt-to-equity ratio of 0.03. The firm has a 50-day moving average of $3.88 and a two-hundred day moving average of $5.55. Edap Tms has a 12 month low of $2.71 and a 12 month high of $8.50. The company has a market cap of $106.49 million, a price-to-earnings ratio of -5.31 and a beta of 0.43.

Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.04). Edap Tms had a negative net margin of 31.68% and a negative return on equity of 36.41%. The company had revenue of $16.97 million during the quarter, compared to analysts’ expectations of $17.16 million. As a group, analysts forecast that Edap Tms will post -0.59 earnings per share for the current fiscal year.

Institutional Trading of Edap Tms

Several institutional investors and hedge funds have recently bought and sold shares of EDAP. Virtu Financial LLC purchased a new stake in shares of Edap Tms in the 1st quarter valued at approximately $82,000. Miracle Mile Advisors LLC purchased a new stake in Edap Tms in the first quarter valued at approximately $136,000. Roubaix Capital LLC acquired a new position in Edap Tms during the first quarter worth $169,000. Finally, Commonwealth Equity Services LLC lifted its stake in Edap Tms by 5.9% during the second quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock worth $388,000 after purchasing an additional 4,000 shares in the last quarter. 62.74% of the stock is currently owned by hedge funds and other institutional investors.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.